Close

Jazz Pharmaceuticals (JAZZ) Completes Enrollment of JZP-110 Phase 3 as Obstructive Sleep Apnea Treatment

Go back to Jazz Pharmaceuticals (JAZZ) Completes Enrollment of JZP-110 Phase 3 as Obstructive Sleep Apnea Treatment